-transparent.png){kind=logo}
Eighteen patients with advanced or recurrent carcinoma of the cervix were treated with a combination of peplomycin, vincristine, mitomycin-C, and cisplatin (POMP). Ten of the 16 evaluable patients (63%) responded, including 4 with a complete response. Median duration of the response was 7 months. Two of 6 with intrapelvic recurrent tumors responded to some extent following intraarterial infusion. The subcutaneous infusion of peplomycin was well accepted by the patients. Toxicity was tolerable. This regimen seemed to be one of the regimens which should be considered for the advanced or recurrent cervical cancer.
Related Publications
H Sugimori, and
T Iwasaka, and
K Fukuda, and
Y Hayashi, and
T Hachisuga
March 1985,
Gan to kagaku ryoho. Cancer & chemotherapy,
H Sugimori, and
T Iwasaka, and
K Fukuda, and
Y Hayashi, and
T Hachisuga
August 1994,
Gan to kagaku ryoho. Cancer & chemotherapy,
H Sugimori, and
T Iwasaka, and
K Fukuda, and
Y Hayashi, and
T Hachisuga
December 1984,
Gan to kagaku ryoho. Cancer & chemotherapy,
H Sugimori, and
T Iwasaka, and
K Fukuda, and
Y Hayashi, and
T Hachisuga
December 1992,
Gynecologic oncology,
H Sugimori, and
T Iwasaka, and
K Fukuda, and
Y Hayashi, and
T Hachisuga
November 1980,
Cancer,
H Sugimori, and
T Iwasaka, and
K Fukuda, and
Y Hayashi, and
T Hachisuga
August 1978,
Obstetrics and gynecology,
H Sugimori, and
T Iwasaka, and
K Fukuda, and
Y Hayashi, and
T Hachisuga
March 2003,
Gan to kagaku ryoho. Cancer & chemotherapy,
H Sugimori, and
T Iwasaka, and
K Fukuda, and
Y Hayashi, and
T Hachisuga
May 1991,
Nihon Sanka Fujinka Gakkai zasshi,
H Sugimori, and
T Iwasaka, and
K Fukuda, and
Y Hayashi, and
T Hachisuga
January 1986,
Cancer,
H Sugimori, and
T Iwasaka, and
K Fukuda, and
Y Hayashi, and
T Hachisuga
August 1990,
Nihon Gan Chiryo Gakkai shi,
